Your browser doesn't support javascript.
loading
NamiRNA-enhancer network of miR-492 activates the NR2C1-TGF-ß/Smad3 pathway to promote epithelial-mesenchymal transition of pancreatic cancer.
Liu, Shanshan; He, Xiaomeng; Di, Yang; Li, Qiuyue; Li, Feng; Ma, Yan; Chen, Litian; Gao, Yushi; Xu, Jingjing; Yang, Shuai; Xu, Li; Corpe, Christopher; Ling, Yun; Zhang, Xiaoyan; Xu, Jianqing; Yu, Wenqiang; Wang, Jin.
Afiliación
  • Liu S; Scientific research Center, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang road, Jinshan District, Shanghai 201508, China.
  • He X; Scientific research Center, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang road, Jinshan District, Shanghai 201508, China.
  • Di Y; Department of Pancreatic Surgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Li Q; Scientific research Center, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang road, Jinshan District, Shanghai 201508, China.
  • Li F; Scientific research Center, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang road, Jinshan District, Shanghai 201508, China.
  • Ma Y; Scientific research Center, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang road, Jinshan District, Shanghai 201508, China.
  • Chen L; Department of Hepatobiliary Surgery, Shanghai Jiaotong University School of Medicine Xinhua Hospital, Shanghai, China.
  • Gao Y; Scientific research Center, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang road, Jinshan District, Shanghai 201508, China.
  • Xu J; State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan 430062, China.
  • Yang S; Scientific research Center, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang road, Jinshan District, Shanghai 201508, China.
  • Xu L; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, and Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
  • Corpe C; Scientific research Center, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang road, Jinshan District, Shanghai 201508, China.
  • Ling Y; Diet and Cardiovascular Health Group, Nutritional Sciences Division, King's College London, 150 Stamford Street, Waterloo, London SE19NH, UK.
  • Zhang X; Scientific research Center, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang road, Jinshan District, Shanghai 201508, China.
  • Xu J; Scientific research Center, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang road, Jinshan District, Shanghai 201508, China.
  • Yu W; Scientific research Center, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang road, Jinshan District, Shanghai 201508, China.
  • Wang J; Scientific research Center, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang road, Jinshan District, Shanghai 201508, China.
Carcinogenesis ; 44(2): 153-165, 2023 05 26.
Article en En | MEDLINE | ID: mdl-36591938
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / MicroARNs Tipo de estudio: Screening_studies Límite: Humans Idioma: En Revista: Carcinogenesis Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / MicroARNs Tipo de estudio: Screening_studies Límite: Humans Idioma: En Revista: Carcinogenesis Año: 2023 Tipo del documento: Article País de afiliación: China